What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Mar 17, 2025 - 13:42
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Read More

Tags:

Previous Article

Workshop managers share concerns over potential MOT recall rule change

Next Article

Health Canada approves RetinaLogik’s VR visual exam platform

Related Posts

Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Tecartus, Brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Development of the Clinical Trials Information System

Development of the Clinical Trials Information System

Feb 20, 2025  0